Document is current
Any future updates will be listed below
-
Authors
Orvain, Corentin https://orcid.org/0000-0002-8717-0824
Milano, Filippo https://orcid.org/0000-0003-3573-2159
Rodríguez-Arbolí, Eduardo
Othus, Megan https://orcid.org/0000-0001-8176-6371
Petersdorf, Effie W.
Sandmaier, Brenda M. https://orcid.org/0000-0002-9767-9739
Appelbaum, Frederick R. https://orcid.org/0000-0002-1839-5069
Walter, Roland B. https://orcid.org/0000-0002-9268-3341
- License Information
-
More Information
Article History
Received: 20 September 2024
Revised: 25 November 2024
Accepted: 4 December 2024
First Online: 12 December 2024
Competing interests
: Employment or Leadership Position: none; Consultant or Advisory Role: none: Stock Ownership: none; Honoraria: none; Research Funding: none; Expert Testimony: none; Patents: none; Other Remuneration: none.
: All patients were treated on Institutional Review Board (IRB)-approved research protocols (all registered with ClinicalTrials.gov) or standard treatment protocols. All analyses conducted herein were performed under a research protocol approved by the Fred Hutchinson Cancer Center’s IRB (#FH2562).
: All patients gave informed consent for study participation in accordance with the Declaration of Helsinki.
